Heartburn drug Zantac recalled as a 'precaution'

GlaxoSmithKline recalls the prescription heartburn medicine Zantac in all markets as a precaution days after the U.S. Food and Drug Administration finds 'unacceptable' levels of a probable cancer-causing impurity in the drug.
Source: CBC | Health - Category: Consumer Health News Tags: News/Health Source Type: news

Related Links:

Sanofi SA said on Friday it would recall popular heartburn medicine Zantac in the United States and Canada, after the medicines were linked with a probable cancer-causing impurity.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
The company ’s announcement follows decisions by Walgreens, CVS and others to remove the drug from their shelves and after other manufacturers recalled their products.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Sanofi SA Drugs (Pharmaceuticals) Cancer Hazardous and Toxic Substances Food and Drug Administration Recalls and Bans of Products Heartburn your-feed-healthcare Zantac United States Canada Source Type: news
As anticipated, recall of the popular heartburn medicine ranitidine (Zantac) has expanded. But we still have more questions than answers. As I mentioned in my original blog post on this topic, the online pharmacy Valisure, which originally alerted the FDA to the issue, found what they called “extremely high levels” of the probable cancer-causing substance N-nitrosodimethylamine (NDMA) in ranitidine products. The FDA has indicated that its own preliminary testing has detected low levels of NDMA in ranitidine. Testing methods may have influenced NMDA results The FDA has clarified that the testing method that...
Source: Harvard Health Blog - Category: Consumer Health News Authors: Tags: Digestive Disorders Drugs and Supplements Source Type: blogs
The pharmaceutical giant had already pulled its common heartburn drug from shelves in Ireland, India and Hong Kong up to two weeks ago. Zantac is still available over-the-counter in Britain.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
There are increasing concerns about the popular heartburn drug Zantac and its generic version because of a chemical that could lead to cancer. Three large pharmacy chains in the U.S. recently pulled the drugs off shelves, following an FDA alert about an "impurity" in the medication. Dr. Jon LaPook recently spoke to two groups of researchers who suspect the problem could be serious for consumers.
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news
GlaxoSmithKline recalls the prescription heartburn medicine Zantac in all markets as a precaution days after the U.S. Food and Drug Administration finds 'unacceptable' levels of a probable cancer-causing impurity in the drug.
Source: CBC | Health - Category: Consumer Health News Tags: News/Health Source Type: news
GlaxoSmithKline on Tuesday said it is recalling the popular heartburn medicine Zantac in all markets as a "precaution", days after the U.S. Food and Drug Administration found "unacceptable" levels of probable cancer-causing impurity in the drug.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Health officials in the UK have recalled four batches of common heartburn drug Zantac over fears they could contain a cancer-causing chemical.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
GlaxoSmithKline Plc is recalling its heartburn medicine Zantac as a "precautionary measure" due to a probable cancer-causing impurity in the drug, Britain's medicines watchdog said on Tuesday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
[Namibian] The Namibia Medicines Regulatory Council has recalled a certain heartburn medicine brand due to a cancer-causing substance recently found in the drug.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news
More News: Cancer | Cancer & Oncology | Food and Drug Administration (FDA) | Health | Heartburn